Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To investigate the efficacy of rovalpituzumab tesirine as third-line and later treatment for subjects with relapsed or refractory delta-like protein 3 (DLL3)-expressing small cell lung cancer (SCLC)
Inclusion criteria
- Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer